LGG-25. ADVANCING RESPONSE ASSESSMENT OF LOW-GRADE GLIOMAS: IDENTIFYING VOLUME CORRELATIONS OF BI-PERPENDICULAR DIAMETER CHANGES WITH MACHINE LEARNING (2024)

Article Navigation

Volume 26 Issue Supplement_4 June 2024

Article Contents

  • Abstract

  • < Previous
  • Next >

Journal Article

,

Gabe Dumbrille

St Jude Children’s Reaserch Hospital

, Memphis, TN,

USA

Search for other works by this author on:

Oxford Academic

,

Silu Zhang

St Jude Children’s Reaserch Hospital

, Memphis, TN,

USA

Search for other works by this author on:

Oxford Academic

,

Giles W Robinson

St Jude Children’s Reaserch Hospital

, Memphis, TN,

USA

Search for other works by this author on:

Oxford Academic

,

Asim K Bag

St Jude Children’s Reaserch Hospital

, Memphis, TN,

USA

Search for other works by this author on:

Oxford Academic

Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.418

Published:

18 June 2024

  • PDF
  • Split View
  • Views
    • Article contents
    • Figures & tables
    • Video
    • Audio
    • Supplementary Data
  • Cite

    Cite

    Gabe Dumbrille, Silu Zhang, Giles W Robinson, Thomas E Merchant, Asim K Bag, LGG-25. ADVANCING RESPONSE ASSESSMENT OF LOW-GRADE GLIOMAS: IDENTIFYING VOLUME CORRELATIONS OF BI-PERPENDICULAR DIAMETER CHANGES WITH MACHINE LEARNING, Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.418

    Close

Search

Close

Search

Advanced Search

Search Menu

Abstract

BACKGROUND

Assessing brain tumor response is key for effective management and clinical trial benchmarks. Traditionally, bi-perpendicular diameter (BPD) measurements have been used to estimate tumor size. However, recent studies suggest volumetric assessment yields a more accurate measure of response and estimate of tumor burden. Advances in technology enable rapid volume assessments. Integrating volumetric analysis into clinical settings is challenged by the absence of volume-based standards aligned with traditional RAPNO bi-dimensional criteria. Our goal was to correlate volume change percentages with bi-perpendicular diameter changes using machine learning.

METHODS

In this project, we compared 2 machine learning models to establish a correlation between percentage change of sum of products of BPD and percent change in volume using a generalized linear model (GLM) and an artificial neural network (ANN). We analyzed 49 patients with low grade glioma, treated with focal irradiation (NCT04065776) (n=27) or mirdametinib (NCT04923126) (n=22). We trained and validated the models at train-test split ratios of 80/20, 75/25, and 70/30, incorporating a proportionate split of tumors from each group. The models were compared on the validation data set using mean-squared error (MSE).

RESULTS

At percentage changes of +25%, -25%, -50%, and -75% in the sum of BPDs, the GLM predicts changes in volume to be +33%, -31%, -59%, and -83%, respectively. For the ANN, the predicted changes are +20%, -29%, -53%, and -78%. The ANN demonstrated a lower MSE compared to the GLM. The two models showed higher concordance in their volume predictions at negative percentage changes in the sum of BPDs: -25% (p=0.15), -50% (p=0.03), and 75% (p=.08)

CONCLUSION

We identified volume percentage changes matching BPD changes per RAPNO criteria using two machine learning methods, both agreeing on negative values. Further testing with a larger dataset is needed to reliably correlate percentage changes.

PDF

This content is only available as a PDF.

© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Issue Section:

Final category: Low Grade Glioma

Download all slides

Advertisem*nt

Citations

Views

1

Altmetric

More metrics information

Metrics

Total Views 1

0 Pageviews

1 PDF Downloads

Since 6/1/2024

Month: Total Views:
June 2024 1

Citations

Powered by Dimensions

Altmetrics

×

Email alerts

Article activity alert

Advance article alerts

New issue alert

Receive exclusive offers and updates from Oxford Academic

Citing articles via

Google Scholar

  • Latest

  • Most Read

  • Most Cited

Leptomeningeal metastases from solid tumors: A SNO and ASCO consensus review on clinical management and future directions
Sex differences in glioblastoma based on tumor subtypes
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
Metabolic Profiling of Glioblastoma Stem Cells Reveals Pyruvate Carboxylase as a Critical Survival Factor and Potential Therapeutic Target
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation

More from Oxford Academic

Clinical Medicine

Medical Oncology

Medicine and Health

Neurology

Books

Journals

Advertisem*nt

LGG-25. ADVANCING RESPONSE ASSESSMENT OF LOW-GRADE GLIOMAS: IDENTIFYING VOLUME CORRELATIONS OF BI-PERPENDICULAR DIAMETER CHANGES WITH MACHINE LEARNING (2024)

References

Top Articles
Latest Posts
Article information

Author: Terence Hammes MD

Last Updated:

Views: 6265

Rating: 4.9 / 5 (69 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Terence Hammes MD

Birthday: 1992-04-11

Address: Suite 408 9446 Mercy Mews, West Roxie, CT 04904

Phone: +50312511349175

Job: Product Consulting Liaison

Hobby: Jogging, Motor sports, Nordic skating, Jigsaw puzzles, Bird watching, Nordic skating, Sculpting

Introduction: My name is Terence Hammes MD, I am a inexpensive, energetic, jolly, faithful, cheerful, proud, rich person who loves writing and wants to share my knowledge and understanding with you.